331 related articles for article (PubMed ID: 525834)
1. [Antiplatelet drugs (author's transl)].
Dechavanne M; Follea G; Trzeciak MC
Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Turpie AG
Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
[TBL] [Abstract][Full Text] [Related]
3. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Bousser MG
J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
[TBL] [Abstract][Full Text] [Related]
4. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Oelz O
Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
[TBL] [Abstract][Full Text] [Related]
5. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
6. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
7. Status of antiplatelet drugs in coronary heart disease.
Mehta J; Mehta P
JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
[No Abstract] [Full Text] [Related]
8. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Weiss HJ
Am Heart J; 1976 Jul; 92(1):86-102. PubMed ID: 785989
[No Abstract] [Full Text] [Related]
9. Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
Hladovec J
Thromb Haemost; 1979 Jun; 41(4):474-8. PubMed ID: 483235
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
de Gaetano G; Cerletti C; Bertelè V
Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
[No Abstract] [Full Text] [Related]
11. Platelet inhibitors in the treatment of thrombosis.
Hirsh J
Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
[No Abstract] [Full Text] [Related]
12. Antiplatelet drugs after myocardial infarction.
Med Lett Drugs Ther; 1980 Mar; 22(6):25-6. PubMed ID: 7360108
[No Abstract] [Full Text] [Related]
13. Antiplatelet therapy.
Turpie AG
Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
[No Abstract] [Full Text] [Related]
14. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
16. [Clinical prevention of thrombosis by antiplatelet agents].
Latour JG
Union Med Can; 1979 Oct; 108(10):1168-86. PubMed ID: 392868
[No Abstract] [Full Text] [Related]
17. Clinical aspects of antiplatelet therapy.
Sherry S
Semin Hematol; 1985 Apr; 22(2):125-34. PubMed ID: 3890191
[No Abstract] [Full Text] [Related]
18. Mode of action of currently used antiplatelet drugs.
de Gaetano G; Bertele' V; Cerletti C
Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
[No Abstract] [Full Text] [Related]
19. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
Poliwoda H; Avenarius HJ
Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
[TBL] [Abstract][Full Text] [Related]
20. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Hirsh J
Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]